These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7037506)

  • 1. The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man.
    Sarson DL; Wood SM; Holder D; Bloom SR
    Diabetologia; 1982 Jan; 22(1):33-6. PubMed ID: 7037506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?
    Sarson DL; Wood SM; Kansal PC; Bloom SR
    Diabetes; 1984 Apr; 33(4):389-93. PubMed ID: 6368294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man.
    Füessl HS; Yiangou Y; Ghatei MA; Goebel FD; Bloom SR
    Eur J Clin Invest; 1990 Oct; 20(5):525-9. PubMed ID: 2124984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS; Ryan AS; Minaker KL; Elahi D
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
    Meier JJ; Nauck MA; Siepmann N; Greulich M; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
    Metabolism; 2003 Dec; 52(12):1579-85. PubMed ID: 14669159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oral galactose on GIP and insulin secretion in man.
    Morgan LM; Wright JW; Marks V
    Diabetologia; 1979 Apr; 16(4):235-9. PubMed ID: 428694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic gastric inhibitory polypeptide. Stimulatory effect on insulin and glucagon secretion in the rat.
    Taminato T; Seino Y; Goto Y; Inoue Y; Kadowaki S
    Diabetes; 1977 May; 26(5):480-4. PubMed ID: 323091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies with gastric inhibitory polypeptide.
    Brown JC; Otte S
    World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide YY inhibits the insulinotropic action of gastric inhibitory polypeptide.
    Guo YS; Singh P; Draviam E; Greeley GH; Thompson JC
    Gastroenterology; 1989 Mar; 96(3):690-4. PubMed ID: 2644149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Hayes TM
    Horm Metab Res; 1989 Jan; 21(1):23-6. PubMed ID: 2647605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of different dietary loads on glucose-dependent insulinotropic polypeptide in subjects with normal glucose tolerance].
    Chen Z; Yan L; Fu XY; Yang HZ; Kuang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2031-4. PubMed ID: 22200706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs.
    Pierluissi J; de Pierluissi R; de Martínez A
    Acta Cient Venez; 2002; 53(1):29-35. PubMed ID: 12216497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.
    Veedfald S; Vedtofte L; Skov-Jeppesen K; Deacon CF; Hartmann B; Vilsbøll T; Knop FK; Christensen MB; Holst JJ
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
    Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.